Nexstim Receives System Orders from Existing Hospital Customers in Finland
15 sept. 2021 02h00 HE
|
Nexstim Oyj
Press release, Helsinki, 15 September 2021 at 9 AM (EEST) Nexstim Receives System Orders from Existing Hospital Customers in Finland Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company")...
Nexstim Reaches 208 Completed Treatment Sessions – Continues to Report a Remission Rate Greater than 50% of MDD Patients in the Patient Registry
20 août 2021 02h00 HE
|
Nexstim Oyj
Press release, Helsinki, 20 August 2021 at 9 AM (EEST) Nexstim Reaches 208 Completed Treatment Sessions – Continues to Report a Remission Rate Greater than 50% of MDD Patients in the Patient Registry...
Six Outstanding Mental Health Researchers Honored by the Brain & Behavior Research Foundation
04 août 2021 10h00 HE
|
Brain & Behavior Research Foundation
New York, Aug. 04, 2021 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) has announced the winners of its 2021 Klerman and Freedman Prizes, which recognize exceptional...
Cognitive Impairment in Psychosis: What it is and How it's Treated - A Free Webinar from the Brain & Behavior Research Foundation
08 juil. 2021 09h00 HE
|
Brain & Behavior Research Foundation
New York, July 08, 2021 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Cognitive Impairment in Psychosis: What it is and How it's Treated” on...
The Headstrong Project, inc. Hires Former Steven A. Cohen Military Family Clinic Clinical Director, Dr. Amy Williams, Ph.D. as its First-Ever Chief Clinical Officer
21 juin 2021 08h00 HE
|
The Headstrong Project
New York, NY, June 21, 2021 (GLOBE NEWSWIRE) -- Headstrong Project Inc., a national-facing mental health treatment practice of choice providing military connected individuals and their families with...
Nexstim Continues to Report Very Promising MDD Treatment Outcomes with Remission Rate Greater than 50%
21 juin 2021 03h30 HE
|
Nexstim Oyj
Press Release, Helsinki, June 21, 2021 at 10:30 AM (EEST) Nexstim Continues to Report Very Promising MDD Treatment Outcomes with Remission Rate Greater than 50% Nexstim Plc (NXTMH:HEX, NXTMS:STO)...
What We Are Learning About Brain Biology and Borderline Personality Disorder - A Free Webinar from the Brain & Behavior Research Foundation
26 mai 2021 09h00 HE
|
Brain & Behavior Research Foundation
New York, May 26, 2021 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “What We Are Learning About Brain Biology and Borderline Personality...
Using Rapid-Acting Brain Stimulation for Treatment-Resistant Depression - A Free Webinar from the Brain & Behavior Research Foundation
04 mai 2021 09h00 HE
|
Brain & Behavior Research Foundation
New York, May 04, 2021 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Using Rapid-Acting Brain Stimulation for Treatment-Resistant Depression” on...
Nexstim Receives an NBT® System Order from a New Therapy Customer in Finland
29 avr. 2021 03h00 HE
|
Nexstim Oyj
Press Release, Helsinki, 29 April 2021 at 10:00 AM (EEST) Nexstim Receives an NBT® System Order from a New Therapy Customer in Finland Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company")...
Nexstim Receives Positive Feedback from Mind Matters Psychiatry MD on Use of Their Two NBT® Systems to Treat MDD
16 avr. 2021 05h00 HE
|
Nexstim Oyj
Press release, Helsinki, 16.04.2021, 12.00 pm (EEST) Nexstim Receives Positive Feedback from Mind Matters Psychiatry MD on Use of Their Two NBT® Systems to Treat MDD Nexstim Plc (NXTMH:HEX,...